Skip to main content

Table 1 Main demographic and clinical characteristics of the present series (30 patients)

From: Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment

Parameter Value
Age (years) 57.13 ± 9.21
Female/male 24/6
Duration of disease (years) 9.43 ± 8.97
Number of of tender joints 16.46 ± 9.1
Number of swollen joints 6.83 ± 4.814
RF positivity 86.70%
Joint erosions 100%
Serum CRP (mg/dl) 3.85 ± 2.74
DAS 28 6.1 ± 1.025
HAQ 1.78 ± 0.422
Previous DMARDs
   Methotrexate 30
   Hydroxycloroquine 26
   Sulfasalazine 18
   Cyclosporin A 19
   Gold (intramuscular) 3
   Leflunomide 1
   Azathioprine 1
  1. Where applicable, values are expressed as ± standard deviation. CRP, C-reactive protein; DAS 28, Disease Activity Score; DMARD, disease-modifying antirheumatic drug; HAQ, Health Assessment Questionnaire; RF, rheumatoid factor.